"Estramustine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.
| Descriptor ID |
D004961
|
| MeSH Number(s) |
D02.455.526.728.650.275 D04.210.500.365.415.248.320
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Estramustine".
Below are MeSH descriptors whose meaning is more specific than "Estramustine".
This graph shows the total number of publications written about "Estramustine" by people in this website by year, and whether "Estramustine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estramustine" by people in Profiles.
-
Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):6094-9.
-
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004 Oct 07; 351(15):1513-20.
-
Estramustine-related hypocalcemia in patients with prostate carcinoma and osteoblastic metastases. Urology. 2001 Jul; 58(1):105.
-
Re: Estramustine phosphate withdrawal syndrome with dramatic pain relief. J Urol. 2000 Apr; 163(4):1261.
-
Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2371-6.